Lifecore Biomedical signs site-transfer agreement supporting pharma commercialization
Lifecore Biomedical (LFCR) signed an agreement for a commercial site transfer supporting a global pharmaceutical company’s tech transfer and commercial manufacturing of a currently marketed drug product.